Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR asthma inhalers, ...
Teva Pharmaceuticals has agreed to pay $35 million to resolve a major antitrust lawsuit alleging that the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback